Aspergillus niger infection in patients with haematological diseases: A report of eight cases

Mycoses

Volumn 47, Issue 3-4, 2004, Pages 163-167

  Fianchi, L ^a   Picardi, M ^b   Cudillo, L ^c   Corvatta, L ^d   Mele, L ^a   Trape G ^a   Girmenia, C ^e   Pagano, L ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Aspergillosis; Aspergillus niger; Leukaemia; Lung; Paranasal sinus; Pneumonia

Indexed keywords

ADULT; AGED; ARTICLE; ASPERGILLOSIS; ASPERGILLUS NIGER; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HEALTH CENTER; HEMATOLOGIC DISEASE; HEMATOLOGY; HUMAN; ITALY; LABORATORY TEST; LUNG INFECTION; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD; MICROBIOLOGY; MULTICENTER STUDY; PARANASAL SINUS DISEASE; PRIORITY JOURNAL;

ADULT; AGED; ANEMIA, APLASTIC; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS NIGER; BRONCHOALVEOLAR LAVAGE FLUID; FATAL OUTCOME; FEMALE; HUMANS; LEUKEMIA; LUNG DISEASES, FUNGAL; LYMPHOMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPUTUM; TREATMENT OUTCOME;

ASPERGILLUS; ASPERGILLUS NIGER;

EID: 2342457694     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2004.00960.x     Document Type: Article

References (31)

1. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996; 23: 608-15.
2. Bow EJ, Loewen R, Cheang MS, Schacter B. Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clin Infect Dis 1995; 21: 361-9.
3. Guiot HF, Fibbe WE, van 'tWout JW. Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis 1994; 18: 525-32.
4. Bodey G, Bueltmann B, Duguid W et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992; 11: 99-109.
5. Oliveri S, Capello G, Napolitano MG, Triolo C, Grillo G. Otomycosis: etiology and analysis of predisposing factor. Boll Ist Sieroter Milan 1984; 63: 537-12.
6. Tisner J, Millan J, Rivas P, Adiego I, Castellote A, Valles H. Otomycosis and topical application of thimerosal: study 152 cases. Acta Otorrhinolaringol Esp 1995; 46: 85-9.
7. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
8. Bodey GP, Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis 1989; 8: 413-37.
9. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implication for management. Blood 1997; 90: 999-1008.
10. Manuel RJ, Kibbler CC. The epidemiology and prevention of invasive aspergillosis. J Hosp Infect 1998; 39: 95-106.
11. Gerson SL, Talbot GH, Lusk E, Hurwitz S, Strom BL, Cassileth PA. Invasive pulmonary aspergillosis in adult acute leukemia: clinical clues to its diagnosis. J Clin Oncol 1985; 3: 1109-16.
12. Capnist G, Chisesi T, Battista R, Dini E. Pulmonary aspergillosis complicating aplastic phase in hematologic patients. Haematologica 1986; 71: 201-4.
13. De Pauw BE, Meis JF. Progress in fighting systemic fungal infections in haematological neoplasia. Support Care Cancer 1998; 6: 31-8.
14. Shpilberg O, Douer D, Goldschmied-Reouven A, Block C, Ben-Bassat I, Ramot B. Invasive aspergillosis in neutropenic patients with haematological disorders. Leuk Lymphoma 1991; 4: 257-62.
15. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459-66.
16. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect Dis 1996; 33: 23-32.
17. Jandrlic M, Kalenic S, Labar B et al. An autopsy study of systemic fungal infections in patients with hematologic malignancies. Eur J Clin Microbiol Infect Dis 1995; 14: 768-74.
18. Pfaffenbach B, Donhuijsen K, Pahnke J et al. Systemic fungal infections in hematologic neoplasms. An autopsy study of 1,053 patients. Medizinische Klinik 1994; 89: 299-304.
19. Andriole VT. Infections with Aspergillus species. Clin Infect Dis 1993; 2 (Suppl. 7): S481-6.
20. Aisner J, Wiernik PH, Schimpff SC. Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Int Med 1977; 86: 539-43.
21. Conneally E, Cafferkey MT, Daly PA, Keane CT, McCann SR. Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients. Bone Marrow Transplant 1990; 36: 403-6.
22. Denning DW, Lee JY, Hostetler JS et al. NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 1994; 97: 135-44.
23. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990; 12: 1147-201.
24. Jeffery GM, Beard ME, Ikram RB et al. Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. Am J Med 1991; 90: 685-92.
25. Kauffman CA. Role of azoles in antifungal therapy. Clin Infect Dis 1996; 2 (Suppl. 22): S148-53.
26. Uzum O, Anaissie EJ. Antifungal prophylaxis in patients with haematological malignancies: a reappraisal. Blood 1995; 86: 2063-72.
27. Walsh TJ, Lee JW, Roilides E, Pizzo PA. Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients. Infect Dis Clin North Am 1996; 10: 365-400.
28. Gercovich FG, Richman SP, Rodriguez V, Luna M, McCredie KB, Bodey GP. Successful control of systemic Aspergillus niger infections in two patients with acute leukaemia. Cancer 1975; 36: 2271-6.
29. Itoh K, Takahashi M, Yagasaki F et al. A neutropenic acute myeloid leukemia patient complicated with chronic otitis media due to Aspergillus niger and yeast-like fungi caused by superinfection. Kansenshogaku Zasshi 1999; 73: 618-22.
30. Pagano L, Girmenia C, Mele L et al. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program. Haematologica 2001; 86: 862-70.
31. Patterson TF, Kirkpatrick WR, White M et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 2000; 79: 250-60.